Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...
A cardiovascular specialty hospital in north Texas decreased time to diagnosis for patients with cardiogenic shock by more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback